Upcoming Webinars

  Calculating the “Benefits” of Smoking: How the FDA’s Economic Model Hinders Tobacco Regulation

Thu, 09/25/2014

Tucked deep in the FDA’s proposed Deeming Regulation, which would assert jurisdiction over cigars, e-cigarettes, and other tobacco products, is a cost-benefit analysis that is setting off alarm bells for public health advocates. The analysis is based on the astonishing premise that the benefits from reductions in smoking have to be discounted significantly to offset the loss in pleasure that smokers suffer when they overcome their addiction.